Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)
Closed Posted
- Opportunity number
- 75N99224R00001
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Advanced Research Projects Agency for Health (ARPA-H) is soliciting abstract submissions by December 15, 2023 and full proposal submissions by February 16, 2024 for its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation program. ARPA-H anticipates making multiple awards to support the coordination of accelerating biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions. Applicants should review the attached Research & Development Solicitation No. 75N99224R00001 for submission requirements and evaluation criteria.
ARPA-H intends to award multiple cooperative agreements through this funding opportunity to support research and development activities. While award values and places of performance are not specified, the purpose of the program is to facilitate collaboration between researchers nationally to coordinate efforts under the Advanced Research Projects Agency for Health, which is an agency within the Department of Health and Human Services.
Synopsis
2 versions
Update #2 · Latest ·
The purpose of Amendment No. 1 to the APECx RDS is to extend the abstract due date to December 15, 2023 at 9:00 AM ET and to extend the proposal due date to February 16, 2024 at 5:00 PM ET. Additional minor changes to the RDS are highlighted in yellow. A revised RDS is attached to this amendment. As a reminder, proposals will be invite-only and an abstract must be submitted to be invited to submit a proposal. Please ensure to follow this opportunity for any further updates. -
The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.
Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 15, 2023, 9:00 AM ET. Proposals will be invite-only and will be due February 16, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal.
Please ensure to follow this opportunity for any updates.
For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/.
Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.
Update #1 ·
The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.
Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 1, 2023, 9:00 AM ET. Proposals will be invite-only and will be due January 19, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal.
Please ensure to follow this opportunity for any updates.
For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/.
Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity